
No data
No data
No data
| CAS Number | 183321-74-6 |
| Catalog Number | AG0027HY(AGN-PC-04S31Q) |
| Chemical Name | 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)- |
| IUPAC Name | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine |
| InChI | InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25) |
| InChI Key | AAKJLRGGTJKAMG-UHFFFAOYSA-N |
| MDL Number | MFCD02089651 |
| Molecular Formula | C22H23N3O4 |
| Molecular Weight | 393.4357 |
| SMILES | C(#C)C=1C=C(C=CC1)NC1=NC=NC2=CC(=C(C=C12)OCCOC)OCCOC |
| UNII | J4T82NDH7E |
| Synonyms | 11C erlotinib,
11C-erlotinib,
358,774, CP,
358774, CP,
CP 358,774,
CP 358774,
CP-358,774,
CP-358774,
CP358,774,
CP358774,
erlotinib,
erlotinib HCl,
erlotinib hydrochloride,
HCl, Erlotinib,
Hydrochloride, Erlotinib,
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine,
OSI 774,
OSI-774,
OSI774,
Tarceva,
Erlotinib,
183321-74-6,
N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine,
OSI-774,
4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline,
UNII-J4T82NDH7E,
4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,
NSC 718781,
CHEMBL553,
J4T82NDH7E,
[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE,
CP358774,
CHEBI:114785,
N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine,
NCGC00164574-01,
AK142763,
DSSTox_CID_26454,
DSSTox_RID_81628,
DSSTox_GSID_46454,
Erlotinib(Tarceva),
CAS-183321-74-6,
NSC718781,
Erlotinib, OS-774,
RG-1415,
Erlotinib [INN:BAN],
SR-05000001460,
erlotinibum,
Erotinib,
R-1415,
erlotinib;,
HSDB 8082,
OSI 744,
Erlotinib free base,
nchembio866-comp3,
Kinome_3317,
n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride,
R 1415,
AC1L42EI,
SCHEMBL8413,
BDBM5446,
BIFK0019,
cid_176870,
GTPL4920,
QUI124,
DTXSID8046454,
OSI-744,
QCR-100,
AAKJLRGGTJKAMG-UHFFFAOYSA-N,
ZX-AFC000128,
HMS2089F05,
HMS3244M19,
HMS3244M20,
HMS3244N19,
HMS3713C22,
AMX10161,
ZINC1546066,
Tox21_112202,
3615AH,
AC-399,
FC0029,
MFCD02089651,
s7786,
STK623143,
[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine,
AKOS000282911,
Tox21_112202_1,
API0024668,
CCG-220420,
CS-0620,
DB00530,
MCULE-7764565391,
RL02337,
Ro-508231,
SB16916,
NCGC00164574-03,
NCGC00164574-05,
NCGC00164574-06,
NCGC00164574-14,
AJ-26877,
AN-15876,
AS-35132,
BC215797,
BCB03_000783,
CJ-05292,
EN002711,
HY-50896,
P443,
SY028059,
AB0017012,
AB1004620,
LS-184395,
AM20090621,
FT-0083688,
FT-0651539,
ST24046689,
KS-00000642,
MFCD02089651 (95%),
A11416,
K00241,
S-7717,
15214-EP2269994A1,
15214-EP2272827A1,
15214-EP2281815A1,
15214-EP2292234A1,
15214-EP2292615A1,
15214-EP2295432A1,
15214-EP2298778A1,
15214-EP2301533A1,
15214-EP2301933A1,
15214-EP2305640A2,
15214-EP2305671A1,
15214-EP2305687A1,
15214-EP2308855A1,
15214-EP2311827A1,
15214-EP2311840A1,
15214-EP2311842A2,
15214-EP2316832A1,
15214-EP2316833A1,
32334-EP2281815A1,
32334-EP2292615A1,
32334-EP2301933A1,
32334-EP2305640A2,
32334-EP2305671A1,
32334-EP2311827A1,
AB01273955-01,
AB01273955-02,
AB01273955-03,
134172-EP2292233A2,
321E746,
I01-1241,
SR-05000001460-1,
SR-05000001460-2,
SR-05000001460-3,
SR-05000001460-6,
BRD-K70401845-003-04-7,
n-(3-ethynylphenyl)(6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amine,
n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy) quinazolin-4-amine,
4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-Quinazolinamine; Erlotinin; Erlotinib Base,
Tarceva,
Erlotinib Base,
erlotinib HCl,
Erlotinib hydrochloride,
Erlotinin,
Erlotinib [INN],
11C-erlotinib,
Tarceva (TN),
D07POC,
Erlotinib, 98% - 1G 1g,
Tyrosine Kinase Inhibitor - Ns,
CP-358774,
C22H23N3O4,
183321-74-6 (free base),
CID176870,
C22-H23-N3-O4,
ACN-036244,
CS-O-31362,
CP 358,774,
CP-358,774,
CP 358774,
2159B,
A3397,
CP-358,774-01,
C400278,
183319-69-9,
AQ4,
n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine,
Erlortinib; 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline,
4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1),
|
| Complexity | 525 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 393.169g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 29 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 393.443g/mol |
| Monoisotopic Mass | 393.169g/mol |
| Rotatable Bond Count | 11 |
| Topological Polar Surface Area | 74.7A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

